In the wake of the latest jury verdict against DuPont, there’s a ruling out now that sets what appears to be the next trial date among the thousands of cases pending against the chemical giant in federal court in Ohio.
U.S. District Judge Edmund Sargus Jr. issued this order which sets up the trial schedule in the suit brought on behalf of Kenneth Vigneron Sr. of Washington County, Ohio. The suit alleges that C8 exposure caused Vigneron to contract including being diagnosed with testicular cancer and hypercholesterolemia.
Sargus scheduled the trial to start on Nov. 14, 2016.
In the meantime, it’s worth noting that shareholders of DuPont and Dow this week approved the huge merger between those two chemical giants, and the group Keep Your Promises DuPont continues to raise questions about this transaction:
Stakeholders want to know how the liabilities will be dealt with once the merger is completed, but beyond that, we need answers about what happens after the company splits into three smaller companies. We have a right to see the separation agreement, and we have a right to see how DuPont, DowDuPont, and any of the final three companies will handle these enormous liabilities. These details are crucial for shareholders, but they are a matter of life and death for thousands of folks in the mid-Ohio Valley.
It is ridiculous that we do not have the basic answers we need as to how our friends and neighbors will be taken care of. It appears that this merger is being carried out with no regard for the human toll it will take on communities in the mid-Ohio Valley and nationwide.